/Companies

Simergent

Chicago, US · Founded 2016 · Delaware LLC · 6 employees on LinkedIn · 3 known investors

Find your way into Simergent

Sign up to see every warm intro you have to Simergent

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Simergent team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies. The company is led by engineers with FDA clearance experience and clinical advisory from nephrologists.

Founders & leadership

Simergent was founded in 2016 by Steve J. Lindo and Rick Pendergraft.

SJSteve J. Lindo
Steve J. LindoCo-founder & CEOSteve J. Lindo is co-founder and CEO of Simergent, a medical device company developing peritoneal dialysis and infusion pump systems. He has prior experience in medical device development, healthcare investment, and management consulting.
RPRick Pendergraft
Rick PendergraftCo-founder & Chief Technology Officer
DJ
Dr. James SloandChief Medical Officer
MR
Michael RohlederManager

Investors · 3

Reported raises · per SEC filings

Form D private placements

$8.8M disclosed across 1 round · 2024

▶$8.8MraisedMar 2026 · 57 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael RohlederExecutive Officer, Director
  • Rick PendergraftExecutive Officer, Director
  • Steve J LindoExecutive Officer, Director
Offering amount
$9.9M
Amount sold
$8.8M
Minimum investment
$18.4K
First sale
Mar 2024
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$218.5K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Simergent do?
Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies. The company is led by engineers with FDA clearance experience and clinical advisory from nephrologists.
Who founded Simergent?
Simergent was founded by Steve J. Lindo, Rick Pendergraft in 2016.
Who are Simergent's investors?
Simergent's investors include Angel Physicians Fund, Pathway Bioventures, Plains Ventures.
How much funding has Simergent raised?
Simergent has disclosed $8.8M raised across 1 round.
Where is Simergent headquartered?
Simergent is headquartered in Chicago, US.